Voloridge Investment Management, LLC Amicus Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

$25.9 Billion
Q4 2024

A detailed history of Voloridge Investment Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 880,112 shares of FOLD stock, worth $8.09 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

880,112

Previous 1,277,609 31.11%

Holding current value

$8.09 Million

Previous $13.6 Million 39.24%

% of portfolio

0.03%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$9.36 - $12.01 $3.72 Million - $4.77 Million	-397,497 Reduced 31.11%	880,112 $8.29 Million
Q3 2024 Nov 14, 2024	SELL	$9.55 - $12.09 $177,878 - $225,188	-18,626 Reduced 1.44%	1,277,609 $13.6 Million
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $153,092 - $198,986	-16,935 Reduced 1.29%	1,296,235 $12.9 Million
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $6.61 Million - $8.24 Million	578,303 Added 78.69%	1,313,170 $15.5 Million
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $7.33 Million - $10.7 Million	734,867 New	734,867 $10.4 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $16,858 - $30,090	2,706 Added 5.98%	47,952 $515,000
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $1.76 Million - $2.78 Million	-222,600 Reduced 83.11%	45,246 $428,000
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $3.26 Million - $4.13 Million	-331,999 Reduced 55.35%	267,846 $3.09 Million
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $2.96 Million - $4.01 Million	-338,887 Reduced 36.1%	599,845 $5.73 Million
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $7.17 Million - $8.82 Million	-823,133 Reduced 46.72%	938,732 $9.05 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $14.7 Million - $38.1 Million	1,596,072 Added 962.69%	1,761,865 $17.4 Million
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $994,045 - $1.84 Million	73,797 Added 80.22%	165,793 $3.83 Million
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $31,954 - $39,391	-2,479 Reduced 2.62%	91,996 $1.3 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $22,415 - $39,695	2,530 Added 2.75%	94,475 $1.43 Million
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $609,595 - $1.03 Million	91,945 New	91,945 $850,000
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $4.53 Million - $5.89 Million	-362,440 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $4.26 Million - $5.72 Million	362,440	362,440 $5.47 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

311M

Call Options Held

467K

Put Options Held

515K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.58B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Amicus Therapeutics, Inc. Transaction History